• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌细胞中 FKBP 脯氨酰异构酶 10(FKBP10)的亚细胞表达模式及其临床意义。

Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance.

机构信息

Department of Navy Environmental and Occupational Health, Faculty of Naval Medicine, Naval Medical University, Shanghai 200433, China.

Department of Pathophysiology, College of Basic Medical Sciences, Naval Medical University, Shanghai 200433, China.

出版信息

Int J Mol Sci. 2023 Jul 13;24(14):11415. doi: 10.3390/ijms241411415.

DOI:10.3390/ijms241411415
PMID:37511172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380463/
Abstract

FKBP10, a member of the FK506-binding protein (FKBP) family, has been implicated in cancer development, although its prognostic function remains controversial. In this study, we analyzed the expression of FKBP10 in tumor tissues using online databases (TCGA) as well as our CRC cohort, and investigated the relationship between its subcellular expression pattern and patient outcomes. Cox regression analysis was used to determine the associations between different subcellular expression patterns of FKBP10 and clinical features of patients. We also discussed the expression level of FKBP10 based on different subcellular expression patterns. Our results showed that FKBP10 was significantly elevated in CRC tissues and exhibited three different subcellular expression patterns which were defined as 'FKBP10-C' (concentrated), 'FKBP10-T' (transitional) and 'FKBP10-D' (dispersive). The FKBP10-D expression pattern was only found in tumor tissues and was associated with unfavorable disease-free survival in CRC patients. High expression levels of FKBP10-C predicted an unfavorable prognosis of recurrence of CRC, while FKBP10-D did not. Our findings suggest that the subcellular expression patterns and expression level of FKBP10 play crucial prognostic roles in CRC, which revealed that FKBP10 may be a viable prognostic and therapeutic target for the diagnosis and treatment of CRC.

摘要

FKBP10 是 FK506 结合蛋白(FKBP)家族的一员,其与癌症的发生发展有关,但其预后功能仍存在争议。在本研究中,我们使用在线数据库(TCGA)和我们的 CRC 队列分析了肿瘤组织中 FKBP10 的表达,并研究了其亚细胞表达模式与患者结局之间的关系。Cox 回归分析用于确定 FKBP10 的不同亚细胞表达模式与患者临床特征之间的关联。我们还根据不同的亚细胞表达模式讨论了 FKBP10 的表达水平。研究结果表明,FKBP10 在 CRC 组织中明显上调,并表现出三种不同的亚细胞表达模式,分别定义为'FKBP10-C'(集中)、'FKBP10-T'(过渡)和'FKBP10-D'(弥散)。'FKBP10-D'表达模式仅在肿瘤组织中发现,与 CRC 患者无病生存不良相关。FKBP10-C 的高表达预示着 CRC 复发的预后不良,而 FKBP10-D 则不然。研究结果表明,FKBP10 的亚细胞表达模式和表达水平在 CRC 中具有重要的预后作用,提示 FKBP10 可能是 CRC 诊断和治疗的一个有前途的预后和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/41ef3434bcbf/ijms-24-11415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/0cdb5845334f/ijms-24-11415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/ffae90a66241/ijms-24-11415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/41ef3434bcbf/ijms-24-11415-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/0cdb5845334f/ijms-24-11415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/ffae90a66241/ijms-24-11415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8206/10380463/41ef3434bcbf/ijms-24-11415-g003.jpg

相似文献

1
Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance.结直肠癌细胞中 FKBP 脯氨酰异构酶 10(FKBP10)的亚细胞表达模式及其临床意义。
Int J Mol Sci. 2023 Jul 13;24(14):11415. doi: 10.3390/ijms241411415.
2
circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity.circREEP3 通过激活 FKBP10 转录和限制抗肿瘤免疫来驱动结直肠癌进展。
Adv Sci (Weinh). 2022 May;9(13):e2105160. doi: 10.1002/advs.202105160. Epub 2022 Mar 1.
3
Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.胃癌中 FKBP10 表达的综合评估及其预后潜力。
Oncol Rep. 2019 Aug;42(2):615-628. doi: 10.3892/or.2019.7195. Epub 2019 Jun 11.
4
Structure of human peptidyl-prolyl cis-trans isomerase FKBP22 containing two EF-hand motifs.人肽基脯氨酰顺反异构酶 FKBP22 含有两个 EF 手模体的结构。
Protein Sci. 2014 Jan;23(1):67-75. doi: 10.1002/pro.2391. Epub 2013 Nov 25.
5
Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.肾癌中FKBP基因家族表达与预后的多组学分析
Front Oncol. 2021 Aug 12;11:697534. doi: 10.3389/fonc.2021.697534. eCollection 2021.
6
A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.一种具有肽基脯氨酰顺反异构酶和伴侣活性的恶性疟原虫FK506结合蛋白(FKBP)。
Mol Biochem Parasitol. 2005 Feb;139(2):185-95. doi: 10.1016/j.molbiopara.2004.10.007.
7
Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain.FK506对缺血大鼠脑进行神经保护后肽基脯氨酰顺反异构酶活性及FK506结合蛋白表达的变化
Neuroscience. 2003;120(4):1037-48. doi: 10.1016/s0306-4522(03)00404-4.
8
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth.FKBP10 通过调控蛋白翻译来维持肺癌生长。
Cell Rep. 2020 Mar 17;30(11):3851-3863.e6. doi: 10.1016/j.celrep.2020.02.082.
9
FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.FK506结合蛋白10,一种特发性肺纤维化潜在的新型药物靶点。
Am J Respir Crit Care Med. 2015 Aug 15;192(4):455-67. doi: 10.1164/rccm.201412-2233OC.
10
FK506-binding protein-type peptidyl-prolyl cis-trans isomerase from a halophilic archaeum, Halobacterium cutirubrum.来自嗜盐古菌红皮盐杆菌的FK506结合蛋白型肽基脯氨酰顺反异构酶。
Gene. 2000 Oct 3;256(1-2):319-26. doi: 10.1016/s0378-1119(00)00378-4.

引用本文的文献

1
FKBP10 Promotes the Muscle Invasion of Bladder Cancer via Lamin A Dysregulation.FKBP10通过核纤层蛋白A失调促进膀胱癌的肌肉浸润。
Int J Biol Sci. 2025 Jan 1;21(2):758-771. doi: 10.7150/ijbs.105265. eCollection 2025.
2
Characterization of an Activated Metabolic Transcriptional Program in Hepatoblastoma Tumor Cells Using scRNA-seq.利用单细胞RNA测序对肝母细胞瘤肿瘤细胞中激活的代谢转录程序进行表征
Int J Mol Sci. 2024 Dec 4;25(23):13044. doi: 10.3390/ijms252313044.

本文引用的文献

1
Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma.FKBP基因家族与肺腺癌预后相关性的深入探究
J Pers Med. 2022 Dec 26;13(1):49. doi: 10.3390/jpm13010049.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
The emerging importance of immunophilins in fibrosis development.免疫亲和素在纤维化发展中的重要作用日益凸显。
Mol Cell Biochem. 2023 Jun;478(6):1281-1291. doi: 10.1007/s11010-022-04591-1. Epub 2022 Oct 27.
4
Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system.生物信息学分析揭示了结直肠癌患者总生存的免疫预后标志物:一种新的机器学习生存预测系统。
BMC Bioinformatics. 2022 Apr 8;23(1):124. doi: 10.1186/s12859-022-04657-3.
5
FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer.FKBP52 和 FKBP51 对乳腺癌中雌激素受体的稳定性具有不同的调节作用。
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2110256119. doi: 10.1073/pnas.2110256119. Epub 2022 Apr 8.
6
circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity.circREEP3 通过激活 FKBP10 转录和限制抗肿瘤免疫来驱动结直肠癌进展。
Adv Sci (Weinh). 2022 May;9(13):e2105160. doi: 10.1002/advs.202105160. Epub 2022 Mar 1.
7
Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.肾癌中FKBP基因家族表达与预后的多组学分析
Front Oncol. 2021 Aug 12;11:697534. doi: 10.3389/fonc.2021.697534. eCollection 2021.
8
A nine-gene signature to improve prognosis prediction of colon carcinoma.一种九基因标志物,可改善结肠癌的预后预测。
Cell Cycle. 2021 May;20(10):1021-1032. doi: 10.1080/15384101.2021.1919827. Epub 2021 May 14.
9
FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis.FKBP10 通过激活 AKT-CREB-PCNA 轴促进神经胶质瘤细胞的增殖。
J Biomed Sci. 2021 Feb 9;28(1):13. doi: 10.1186/s12929-020-00705-3.
10
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth.FKBP10 通过调控蛋白翻译来维持肺癌生长。
Cell Rep. 2020 Mar 17;30(11):3851-3863.e6. doi: 10.1016/j.celrep.2020.02.082.